Fig. 2From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort studyPatient distribution according to the modified or unmodified clopidogrel maintenance dose in the VASP-guided group. VASP: vasodilator-stimulated phosphoproteinBack to article page